The state Health Department released additional coronavirus data on Saturday that gives a clearer picture of which counties and age groups have been hardest hit by the pandemic so far. The figures are summarized in the charts below.

The data confirm that the virus is concentrated in the New York City metropolitan area, with the city itself accounting for almost three-quarters of the 3,565 deaths through Friday.

When adjusted for population, the death rates in the neighboring counties of Nassau and Westchester have been almost as high as the city’s, with Rockland and Suffolk not far below.


This is an installment in a special series of #NYCoronavirus chronicles by Empire Center analysts, focused on New York’s state and local policy response to the Coronavirus pandemic.


Mortality has been concentrated in higher age groups, consistent with the pattern around the world. Of those who have died, 93 percent have been over 50, 82 percent over 60, 64 percent over 70 and 37 percent over 80.

As with deaths, the number of confirmed cases has been concentrated in New York City and the surrounding suburbs, with Queens and Brooklyn having the largest number of positive tests.

When adjusted for population, however, Rockland, Westchester and Nassau have the highest rates of positive tests per 10,000 residents. This could reflect varying patterns of testing, but it might also foreshadow where the worst of the pandemic will hit next.

deaths-by-county-4-3-3445736
Source: New York State Department of Health (click to enlarge)

 

dpm-by-county-4-3-7343587
Source: New York State Department of Health (click to enlarge)

 

deaths-by-age-4-3-2464677
Source: New York State Department of Health (click to enlarge)

 

cases-by-county-4-3-8365973
Source: New York State Department of Health (click to enlarge)

 

case-rate-by-county-4-3-7785016
Source: New York State Department of Health (click to enlarge)

 

 

About the Author

Bill Hammond

As the Empire Center’s senior fellow for health policy, Bill Hammond tracks fast-moving developments in New York’s massive health care industry, with a focus on how decisions made in Albany and Washington affect the well-being of patients, providers, taxpayers and the state’s economy.

Read more by Bill Hammond

You may also like

The Attorney General’s MFCU SNAFU

Attorney General Letitia James' latest fight with the Trump administration focuses on New York's Medicaid Fraud Control Unit, a federally funded agency housed in James' office. On T Read More

Healthcare Revelations in the Enacted Budget Financial Plan

The state financial plan published on June 10 disclosed key information about healthcare revenue and spending that lawmakers had not made public when approving the annual budget two weeks before. Read More

Federal Suit Traces Medicaid Fraud to the Top of NYS Government

The Trump administration's latest salvo against Medicaid fraud takes aim at a different kind of target – two high-ranking New York officials along with a major state contractor. A Read More

Healthcare Highlights in the New State Budget

Governor Hochul's focus on affordability seems to have skipped over the healthcare portions of the new state budget. The deal finalized May 27 Read More

Lawmakers Consider Hiking Fees for Filling Prescriptions

UPDATE: The proposal discussed below passed the Assembly Friday evening by an unofficial vote of 133-0. Having previously been approved by the Senate, the bill will head to Governor Hochul's desk for her signature or ve Read More

Budget Deal Reportedly Earmarks $100M for 1199 and Extends MCO Tax

As Governor Hochul and legislative leaders rush to finalize the overdue state budget, outlines of some healthcare-related deals have begun to emerge from the closed-door negotiations. Read More

Albany Wavers on Shutting Down a Medicaid Racket

As Washington threatens to crack down on fraud and abuse in New York's Medicaid program, state legislators are doing their best to demonstrate why federal intervention is needed. A Read More

Getting to the Bottom of the 340B Drug Discount Boondoggle

Some of New York's largest and most prosperous hospitals are reporting rapidly growing amounts of revenue from pharmacy sales – most of it apparently flowing from a controversial drug discount program known as 340B. Read More